Retinal Vein Occlusion
Links shared publicly online about this topic.
- 1,190total visits
Retinal Vein Occlusion
View full resource at my.clevelandclinic.org
Tags: Circulation, Stroke, Eye, Vision, Thrombotic Event
Most Recently Shared on May 5, 2010 at 3:45 pm By:
Focus on Your Vision Insight: Understanding retinal vein occlusion, or “eye stroke.†http://ow.ly/14idx
Can Viagra blind you?
eyedocnews.com — “the authors cite a case of branch retinal artery oclusion after viagra” View full resource at eyedocnews.com
Most Recently Shared on December 16, 2011 at 10:35 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Can Viagra Cause a Retinal Artery Occlusion?: Retinal Physician: The authors cite a case report of a br... http://t.co/z63YCKjN
Current Insight : American Academy of Ophthalmology
one.aao.org — “Current Insight : American Academy of Ophthalmology” View full resource at one.aao.org
Most Recently Shared on November 6, 2011 at 2:38 pm By:
Rob Melendez, MD, MBA Active Health Library, Doctor, Surgeon, Ophthalmologist, and Physician
Current Insight : American Academy of Ophthalmology http://t.co/yjSz3AlM
aspirin contraindicated in retinal vein occlusion
eyedocnews.com — “aspirin and plavix made the vision worse in central retinal vein occlusions” View full resource at eyedocnews.com
Most Recently Shared on August 30, 2011 at 10:05 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Aspirin Contraindicated in Central Retinal Vein Occlusion: Ophthalmology: Here’s an interesting, counte... http://t.co/Qe6W2fI
Lucentis receives Health Canada approval for treatment of retinal vein occlusion
news-medical.net — “Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.” View full resource at news-medical.net
Most Recently Shared on August 18, 2011 at 1:20 pm By:
Stroke News: Lucentis receives Health Canada approval for treatment of retinal vein occlusion: Following a pri... http://t.co/Xp96seT
Ozurdex recommended for treating macular oedema - Ophthalmology Times Europe
oteurope.com — “The National Institute for Health and Clinical Excellence (NICE) has recommended Ozurdex for the treatment of macular oedema caused by central retinal vein occlusion (CRVO).” View full resource at oteurope.com
Most Recently Shared on June 16, 2011 at 12:34 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
News Update: Ozurdex recommended for treating macular oedema http://ow.ly/1dgQww
Intravitreal implant recommended for treatment of macular edema due to retinal vein occlusion
osnsupersite.com — “MARLOW, England — The National Institute for Health and Clinical Excellence has recommended a dexamethasone intravitreal implant for treati” View full resource at osnsupersite.com
Most Recently Shared on June 7, 2011 at 4:45 pm By:
#Intravitreal implant recommended for treatment of #macular edema due to #retinal vein occlusion: http://ht.ly/5cbpr
PR Newswire for Journalists :: Welcome
media.prnewswire.com — “PR Newswire for Journalists :: Welcome” View full resource at media.prnewswire.com
Most Recently Shared on June 6, 2011 at 9:05 am By:
NICE set to recommend Ozurdex (intravitreal dexamethasone) for macular oedema secondary to retinal vein occlusion: http://bit.ly/kc3AwA
Lucentis(R) (Ranibizumab) Launched In The UK For The Treatment Of Vision Loss Due To Macular Oedema Secondary To Retinal Vein Occlusion (RVO)
medicalnewstoday.com — “Novartis Pharmaceuticals UK Ltd today announced that Lucentis® (ranibizumab) has launched in the UK for the treatment of visual impairment due to macular oedema secondary to Retinal Vein Occlu” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 9:05 am By:
Lucentis(R) (Ranibizumab) Launched In The UK For The Treatment Of Vision Loss Due To Macular Oedema Secondary To Retin... http://mnt.to/3WNc
Statins Before PCI Cuts Damage in Tiniest Veins (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Pretreating PCI patients with pravastatin can help reduce microvascular dysfunction induced by PCI regardless of side branch occlusion, Japanese researchers found.” View full resource at qualitypointtech.net
Most Recently Shared on May 17, 2011 at 5:00 pm By:
Statins Before PCI Cuts Damage in Tiniest Veins (CME/CE): (MedPage Today) -- Pretreating PCI patients with pravast... http://bit.ly/jfkxpP
Ranibizumab can be used for long-term CRVO - Ophthalmology Times Europe
oteurope.com — “Visual acuity and central retinal thickness in patients with central retinal vein occlusion (CRVO) have been improved with intravitreal ranibizumab treatment, according to a study published in Retina.” View full resource at oteurope.com
Most Recently Shared on May 10, 2011 at 12:34 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
News Update: Ranibizumab can be used for long-term CRVO - Visual acuity and central retinal thickness in patients wi... http://ow.ly/1cAkek
Temporary Balloon Occlusion to Facilitate Vascular Plug Occlusion of a Reopened Left Superior Caval Vein After Surgery for Congenital Heart Disease | Vascular Disease Management
vasculardiseasemanagement.com — “Temporary Balloon Occlusion to Facilitate Vascular Plug Occlusion of a Reopened Left Superior Caval Vein After Surgery for Congenital Heart Disease | Vascular Disease Management” View full resource at vasculardiseasemanagement.com
Most Recently Shared on May 9, 2011 at 6:34 pm By:
Vascular Disease Man Medical Journal
Our May issue is officially uploaded! Be sure to read this new article about temporary balloon occlusion. http://fb.me/MrHybAOS
Phase 3 Study of VEGF Trap-Eye for Macular Edema - MPR
empr.com — “Regeneron and Bayer HealthCare announced positive results from their Phase 3 GALILEO study of VEGF Trap-Eye (aflibercept ophthalmic solution) for the treatment of patients with macular edema due to central retinal vein occlusion.” View full resource at empr.com
Most Recently Shared on April 28, 2011 at 2:56 pm By:
MPR News: Phase 3 Study of VEGF Trap-Eye for Macular Edema: Regeneron and Bayer HealthCare announced positive re... http://bit.ly/iumVUy
Regeneron And Bayer Report Positive Results For VEGF Trap-Eye In Second Phase 3 Study In Central Retinal Vein Occlusion
medicalnewstoday.com — “Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the Phase 3 GALILEO study in patients” View full resource at medicalnewstoday.com
Most Recently Shared on April 28, 2011 at 7:05 am By:
Regeneron And Bayer Report Positive Results For VEGF Trap-Eye In Second Phase 3 Study In Central Retinal Vein Occlusion http://mnt.to/3V7b
intravitreal plasmin improves macular edema in vein occlusion
eyedocnews.com — “intravitreal injection of plasmin dramatically improved macular edema in branch retinal vein occlusion” View full resource at eyedocnews.com
Most Recently Shared on April 11, 2011 at 10:14 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Intravitreal Plasmin Effective in Vein Occlusion: Archives: Researchers found that an injection of auto... http://bit.ly/i2s4Gq
Lucentis Approved in Europe to Treat Macular Edema
eyedocnews.com — “Approval based on two studies showing Lucentis improved vision in patients with BRVO and CRVO” View full resource at eyedocnews.com
Most Recently Shared on March 21, 2011 at 6:16 pm By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Lucentis Approved in Europe to Treat Patients With Macular Edema Secondary to Retinal Vein Occlusion: N... http://bit.ly/eiLIIM
Advertisement
